Urology

Your Article Summary

See Latest Articles

Intravesical botulinum toxin type A in chronic interstitial cystitis: Results of a pilot study
The Surgeon - Journal of the Royal College of Surgeons at Edinburgh and Ireland, 11/27/07

Ramsay, A. K., et al. - Current data point to an antinociceptive effect of BTX-A that is separate from its neuromuscular activity. Animal studies have shown evidence of an afferent effect of BTX-A and several clinical studies have also proven the analgesic effects of BTX-A in chronic visceral pain syndromes

Today in Bladder...keeping you current

Receive free subspecialty "5-minute updates" via email

Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09

Emerging targeted therapies for bladder cancer: a disease waiting for a drug
Cancer and Metastasis Reviews, 12/17/09

Laparoscopic Pyeloplasty: A Versatile Alternative to Open Pyeloplasty
Urologia Internationalis, 12/17/09

 See all of Bladder

Today in Infections/STDs...keeping you current

Receive free subspecialty "5-minute updates" via email

Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux
Expert Review of Anti-infective Therapy, 12/17/09

Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec
Canadian Journal of Infectious Diseases, 12/17/09

Hidden high-grade vesicoureteral reflux is the main risk factor for chronic renal damage in children under the age of two years with first urinary tract infection
Scandinavian Journal of Urology and Nephrology, 12/15/09

 See all of Infections/STDs